Chemours reported third quarter 2026 net sales of $1.54 billion, a 3% year-over-year increase that slightly exceeded analyst expectations of $1.53 billion. While the company achieved strong results in its Titanium Technologies and Advanced Performance Materials segments, adjusted EPS of $0.21 fell short of the $0.27 consensus estimate. Results were impacted by a 9% volume decline in the Thermal & Specialized Solutions segment, which faced difficult comparisons against elevated demand in the prior-year quarter.
Key Highlights
- Titanium Technologies (TT) segment sales rose 11% year-over-year to $680 million, with Adjusted EBITDA surging 240% to $85 million driven by a 10% increase in global pricing.
- Thermal & Specialized Solutions (TSS) Adjusted EBITDA fell 30% year-over-year to $136 million, though this landed within the upper half of management's previously issued guidance range of $125 million to $140 million.
- Advanced Performance Materials (APM) sales grew 8% year-over-year to $337 million, led by a 26% increase in Performance Solutions revenue from AI infrastructure and semiconductor demand.
- The company recognized a $150 million receipt from a PFAS insurance memorandum of understanding and completed the sale of its Kuan Yin property for total net consideration of approximately $340 million.
- Management updated full-year 2026 guidance, forecasting Adjusted EBITDA between $775 million and $800 million and capital expenditures of $220 million to $230 million.